[Cost effectiveness of biologicals: high costs are the other face of success].

Translated title of the contribution: [Cost effectiveness of biologicals: high costs are the other face of success].

P.M.J. Welsing, M. Bijl, A.A. van Bodegraven, W.F. Lems, E. Prens, J.W. Bijlsma

Research output: Contribution to journal › Article › Professional

Translated title of the contribution	[Cost effectiveness of biologicals: high costs are the other face of success].
Original language	Undefined/Unknown
Pages (from-to)	A3026-A3026
Number of pages	1
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	155
Publication status	Published - 2011

Access to Document

@article{a1d21c3b2ccc4060b958b536a81ed30c,

title = "[Cost effectiveness of biologicals: high costs are the other face of success].",

author = "P.M.J. Welsing and M. Bijl and {van Bodegraven}, A.A. and W.F. Lems and E. Prens and J.W. Bijlsma",

year = "2011",

language = "Undefined/Unknown",

volume = "155",

pages = "A3026--A3026",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

}

TY - JOUR

T1 - [Cost effectiveness of biologicals: high costs are the other face of success].

AU - Welsing, P.M.J.

AU - Bijl, M.

AU - van Bodegraven, A.A.

AU - Lems, W.F.

AU - Prens, E.

AU - Bijlsma, J.W.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0028-2162

VL - 155

SP - A3026-A3026

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

ER -